图片来源：Vaxart公司官网

参考资料

Flitter BA, Greco SN, Lester CA, et al. An oral norovirus vaccine tablet was safe and elicited mucosal immunity in older adults in a phase 1b clinical trial. Science Translational Medicine. 2025;17(788):eads0556. doi:10.1126/scitranslmed.ads0556

Kim L, Liebowitz D, Lin K, et al. Safety and immunogenicity of an oral tablet norovirus vaccine, a phase I randomized, placebo-controlled trial. JCI Insight. 2018;3(13):e121077, 121077. doi:10.1172/jci.insight.121077

Positive topline data from Phase II trial of Vaxart’s norovirus vaccine pill. Accessed May 1, 2025. https://www.clinicaltrialsarena.com/news/positive-topline-vaxart-norovirus-vaccine-pill/

This Week in Virology (TWiV) Episode 1209, https://www.microbe.tv/twiv/twiv-1209/

Vaxart. Vaxart, Inc. –Vaxart Completes Enrollment in Phase 1 Trial for its Norovirus Oral Pill Vaccine Candidate. Vaxart. April 30, 2025. Accessed May 1, 2025. https://investors.vaxart.com/news-releases/news-release-details/vaxart-completes-enrollment-phase-1-trial-its-norovirus-oral

欢迎来到医食参考新媒体矩阵

2023年疫苗接种攻略

阳过了，该怎么打疫苗？最全接种指导手册来了

撰写| CNVAC

校稿| Gddra编审| Hide / Blue sea

编辑 设计| Alice